Hage, F. G., Bourque, J. M., Pandey, S., Shah, N. R., Soman, P., Abbott, B. G., Abidov, A., Aggarwal, N. R., AlJaroudi, W., Bhambhvani, P. G., Bokhari, S., Dorbala, S., Doukky, R., Duran, J. M., Einstein, A. J., Gallagher, D., Hendel, R. C., Jaber, W., Kattan, C. G., … Sperry, B. W. (2024). American Society of Nuclear Cardiology quality metrics for cardiac amyloid radionuclide imaging. Journal of Nuclear Cardiology, 40, 102041. https://doi.org/10.1016/j.nuclcard.2024.102041

Zureigat, H., Civieri, G., Abohashem, S., Osborne, M. T., Solomon, D. H., Giles, J. T., Bathon, J., Massarotti, E., Unizony, S., & Tawakol, A. (2024). Improvement in joint inflammation is accompanied by reduction in arterial inflammation: Tocilizumab in rheumatoid arthritis. Journal of Nuclear Cardiology, 33, 101813. https://doi.org/10.1016/j.nuclcard.2024.101813

Chan, N., Einstein, A. J., Griffin, J. M., Rosenblum, H., Teruya, S., Cuomo, M., De Los Santos, J., DeLuca, A., Johnson, L. L., Kinkhabwala, M. P., Leb, J. S., Mintz, A., Fine, D., Helmke, S., Muralidhar, V., Pandey, S., Sabogal, N., Saith, S. E., Winburn, M., … Maurer, M. S. (2023). Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases. Journal of Nuclear Cardiology, 30(6), 2531–2539. https://doi.org/10.1007/s12350-023-03310-7

Pandey, S., Teruya, S., Rodriguez, C., Deluca, A., Kinkhabwala, M., Johnson, L. L., Fine, D., Sabogal, N., Winburn, M., Castillo, M., Bhatia, K., Malkovskaya, R., Raiszadeh, F., Kurian, D., Miller, E. J., Einstein, A. J., Maurer, M. S., & Ruberg, F. L. (2023). Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc99m pyrophosphate (PYP) imaging for diagnosis of transthyretin (ATTR) cardiac amyloidosis: the SCAN-MP study. Journal of Nuclear Cardiology, 30(4), 1414–1419. https://doi.org/10.1007/s12350-023-03203-9

DePuey, E. G. (2023). Incidental scan findings in cardiac amyloid scintigraphy. Journal of Nuclear Cardiology, 30(4), 1671–1687. https://doi.org/10.1007/s12350-023-03218-2

Smiley, D., Einstein, A. J., Chan, N., Mintz, A., Santana, D. D., Shetty, M., Sekulic, M., Goldner, K., Wall, J., Helmke, S., & Maurer, M. S. (2023). In the thick of it: hereditary cardiac amyloidosis identified by 124I-AT-01 PET imaging but not cardiac MRI or SPECT 99mTc pyrophosphate scintigraphy. Journal of Nuclear Cardiology, 30(3), 1258–1262. https://doi.org/10.1007/s12350-023-03267-7

Hage, F. G., Einstein, A. J., Ananthasubramaniam, K., Bourque, J. M., Case, J., DePuey, E. G., Hendel, R. C., Henzlova, M. J., Shah, N. R., Abbott, B. G., Al Jaroudi, W., Better, N., Doukky, R., Duvall, W. L., Malhotra, S., Pagnanelli, R., Peix, A., Reyes, E., Saeed, I. M., … Winchester, D. E. (2023). Quality metrics for single-photon emission computed tomography myocardial perfusion imaging: an ASNC information statement. Journal of Nuclear Cardiology, 30(2), 864–907. https://doi.org/10.1007/s12350-022-03162-7

Al-Mallah, M. H., Bateman, T. M., Branch, K. R., Crean, A., Gingold, E. L., Thompson, R. C., McKenney, S. E., Miller, E. J., Murthy, V. L., Nieman, K., Villines, T. C., Yester, M. V., Einstein, A. J., & Mahmarian, J. J. (2022). 2022 ASNC/AAPM/SCCT/SNMMI guideline for the use of CT in hybrid nuclear/CT cardiac imaging. Journal of Nuclear Cardiology, 29(6), 3491–3535. https://doi.org/10.1007/s12350-022-03089-z

Han, D., Rozanski, A., Gransar, H., Tzolos, E., Miller, R. J. H., Sharir, T., Einstein, A. J., Fish, M. B., Ruddy, T. D., Kaufmann, P. A., Sinusas, A. J., Miller, E. J., Bateman, T. M., Dorbala, S., Di Carli, M., Liang, J. X., Hu, L.-H., Dey, D., Berman, D. S., & Slomka, P. J. (2022). Comparison of diabetes to other prognostic predictors among patients referred for cardiac stress testing: A contemporary analysis from the REFINE SPECT Registry. Journal of Nuclear Cardiology, 29(6), 3003–3014. https://doi.org/10.1007/s12350-021-02810-8

Ibrahim, J., Nieves, R. A., Barakat, A. F., Hynal, K., Shpilsky, D., & Soman, P. (2022). DSPECT-specific normative limits for left ventricular size and function. Journal of Nuclear Cardiology, 29(6), 3293–3299. https://doi.org/10.1007/s12350-022-02932-7

Han, D., Rozanski, A., Miller, R. J. H., Sharir, T., Einstein, A. J., Fish, M. B., Ruddy, T. D., Kaufmann, P. A., Sinusas, A. J., Miller, E. J., Bateman, T. M., Dorbala, S., Di Carli, M., Liang, J. X., Dey, D., Berman, D. S., & Slomka, P. J. (2022). Prevalence and predictors of automatically quantified myocardial ischemia within a multicenter international registry. Journal of Nuclear Cardiology, 29(6), 3221–3232. https://doi.org/10.1007/s12350-021-02829-x

Bourque, J. M., Einstein, A. J., & Dorbala, S. (2022). ASNC Imaging Indications (ASNC-I2): Multisocietal indications for radionuclide imaging in the multimodality context—Series rationale and methodology. Journal of Nuclear Cardiology, 29(5), 2667–2678. https://doi.org/10.1007/s12350-021-02800-w

Eisenberg, E., Miller, R. J. H., Hu, L.-H., Rios, R., Betancur, J., Azadani, P., Han, D., Sharir, T., Einstein, A. J., Bokhari, S., Fish, M. B., Ruddy, T. D., Kaufmann, P. A., Sinusas, A. J., Miller, E. J., Bateman, T. M., Dorbala, S., Di Carli, M., Liang, J. X., … Slomka, P. J. (2022). Diagnostic safety of a machine learning-based automatic patient selection algorithm for stress-only myocardial perfusion SPECT. Journal of Nuclear Cardiology, 29(5), 2295–2307. https://doi.org/10.1007/s12350-021-02698-4

Miller, R. J. H., Hauser, M. T., Sharir, T., Einstein, A. J., Fish, M. B., Ruddy, T. D., Kaufmann, P. A., Sinusas, A. J., Miller, E. J., Bateman, T. M., Dorbala, S., Di Carli, M., Huang, C., Liang, J. X., Han, D., Dey, D., Berman, D. S., & Slomka, P. J. (2022). Machine learning to predict abnormal myocardial perfusion from pre-test features. Journal of Nuclear Cardiology, 29(5), 2393–2403. https://doi.org/10.1007/s12350-022-03012-6

Miller, E. J., Campisi, R., Shah, N. R., McMahon, S., Cuddy, S., Gallegos-Kattan, C., Maurer, M. S., Damy, T., Slart, R. H. J. A., Bhatia, K., & Einstein, A. J. (2022). Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement. Journal of Nuclear Cardiology, 29(5), 2748–2760. https://doi.org/10.1007/s12350-022-03059-5

Lin, H., Zhang, X., Einstein, A. J., & Tang, G. (2022). Serial Tc-99m MDP scintigraphy demonstrating increasing cardiac uptake over time in a patient with light-chain cardiac amyloidosis. Journal of Nuclear Cardiology, 29(4), 2024–2028. https://doi.org/10.1007/s12350-022-02987-6

Thompson, R. C., Phillips, L. M., Dilsizian, V., Gutierrez, D. P., Einstein, A. J., Crews, S. F., Skali, H., Jih, F. K. Y., Dondi, M., Gimelli, A., Bateman, T. M., Al-Mallah, M. H., Ghesani, M., Dorbala, S., & Calnon, D. A. (2022). Update on guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: Emphasis on transition to chronic endemic state. An information statement from ASNC, IAEA, and SNMMI. Journal of Nuclear Cardiology, 29(4), 2013–2018. https://doi.org/10.1007/s12350-022-02984-9

Klein, E., Miller, R. J. H., Sharir, T., Einstein, A. J., Fish, M. B., Ruddy, T. D., Kaufmann, P. A., Sinusas, A. J., Miller, E. J., Bateman, T. M., Dorbala, S., Di Carli, M., Otaki, Y., Gransar, H., Liang, J. X., Dey, D., Berman, D. S., & Slomka, P. J. (2022). Automated quantitative analysis of CZT SPECT stratifies cardiovascular risk in the obese population: Analysis of the REFINE SPECT registry. Journal of Nuclear Cardiology, 29(2), 727–736. https://doi.org/10.1007/s12350-020-02334-7